KUALA LUMPUR (Jan 24): TMC Life Sciences Bhd’s net profit rose 11.7% to RM7.07 million for the first financial quarter ended Nov 30, 2018 (1QFY19) from RM6.34 million a year ago, on higher patient load, higher intensity cases handled and additional consultants recruited.

This resulted in a higher earnings per share of 0.41 sen compared with 0.36 sen in 1QFY18.

Quarterly revenue also grew 13% to RM47.16 million from RM41.73 million a year ago.   

On prospects, TMC Life Sciences said it will continue to adopt measures to maintain growth by introducing more services, while ramping up outreach and marketing efforts to ensure that it is the healthcare service provider of choice for private patients, including the new Thomson TCM Centre in Puchong, Selangor last November in the provision of traditional complementary medicine services.

"The group's expansion project at Thomson Hospital Kota Damansara, Selangor is also progressing on schedule in its construction work after the completion piling work in July last year, while the Thomson Iskandar Medical Hub in Johor Baru is in the midst of obtaining the relevant regulatory approvals and has begun piling work in December 2018," it added.

Shares of TMC Life Sciences closed up 0.5 sen or 0.69% to 73.5 sen today, with 320,500 shares done, for a market value of RM1.28 billion.